Trial intelligence / Profile preview

Budesonide HFA vs CFC in Asthma

NCT00667992Phase 3Completed

Sponsor
AstraZeneca
Start
Apr 2008
Primary completion
May 2009
Modality
Small Molecules
Countries
2
01

Overview

A Phase 3 trial of budesonide in asthma, sponsored by AstraZeneca. Started Apr 2008; status: completed.

02

Drugs

budesonide
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00667992.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00667992.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call